We are live on ! Find out more
FULC icon

Fulcrum Therapeutics
FULC

68 hedge funds and large institutions have $317M invested in Fulcrum Therapeutics in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 16

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

24% more capital invested

Capital invested by funds: $256M → $317M (+$60.8M)

3% more funds holding

Funds holding: 66 → 68 (+2)

1.64% more ownership

Funds ownership: 80.74% → 82.38% (+1.6%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
68
Holders Change
+2
Holders Change %
+3.03%
% of All Funds
1.19%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
10
Increased
24
Reduced
16
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Suvretta Capital Management
New York
+$18.9M
2
RI
RTW Investments
New York
+$14M
3
CAC
Cowen and Company
New York
+$10.9M
4
DCM
Driehaus Capital Management
Illinois
+$10.8M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.23M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$9.43M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$5.3M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$2.69M
4
OM
Opaleye Management
Massachusetts
-$1.03M
5
ACP
Acuta Capital Partners
California
-$742K
Name Holding Trade Value Shares
Change 		Change in
Stake
PHP
26
Parkman Healthcare Partners
Connecticut
$1.48M +$1.55M +125,738 New
FT
27
Fiduciary Trust
Massachusetts
$1.47M – – –
SCM
28
Silverarc Capital Management
Massachusetts
$1.43M +$1.3M +105,093 +648%
PIM
29
Platinum Investment Management
Australia
$984K – – –
Morgan Stanley
30
Morgan Stanley
New York
$799K -$384K -31,093 -31%
BFM
31
Boothbay Fund Management
New York
$599K +$12.1K +976 +2%
DGM
32
Darwin Global Management
Jersey
$587K -$142K -11,445 -19%
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
$587K +$616K +49,815 New
Charles Schwab
34
Charles Schwab
California
$514K +$81.8K +6,616 +18%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$497K -$9.46K -765 -2%
CTB
36
Country Trust Bank
Illinois
$440K – – –
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$372K +$391K +31,594 New
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$353K – – –
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$303K +$36.9K +2,986 +13%
PP
40
PDT Partners
New York
$240K -$41.6K -3,367 -14%
BM
41
Brandywine Managers
Delaware
$240K – – –
State of Wisconsin Investment Board
42
State of Wisconsin Investment Board
Wisconsin
$234K – – –
EGM
43
Engineers Gate Manager
New York
$202K -$33K -2,667 -13%
AllianceBernstein
44
AllianceBernstein
Tennessee
$185K – – –
MA
45
MYDA Advisors
New York
$185K +$195K +15,737 New
Goldman Sachs
46
Goldman Sachs
New York
$169K -$6.06K -490 -3%
Two Sigma Investments
47
Two Sigma Investments
New York
$165K -$169K -13,668 -49%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$146K +$6.06K +490 +4%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$145K – – –
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$135K +$142K +11,460 New
1
2
3 4

FULC Hedge Fund Activity: Q1 2021 in Review

68 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Fulcrum Therapeutics (FULC) for Q1 2021, worth a combined $317M — up 24% from $256M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new FULC positions and 8 closed out — a net gain of 2 holders — while 24 added to existing stakes and 16 trimmed.

The largest buyer was Suvretta Capital Management, opening a new position worth an estimated $18.9M. The largest seller was Point72 Asset Management, cutting an estimated $9.43M.

  • 68 institutional investors held Fulcrum Therapeutics (FULC) as of Q1 2021, up from 66 in Q4 2020.
  • Funds reported $317M of Fulcrum Therapeutics stock for Q1 2021, up 24% quarter-over-quarter.
  • 10 funds opened new Fulcrum Therapeutics positions in Q1 2021 and 8 closed out, a net change of +2 holders.
  • The largest Fulcrum Therapeutics buyer in Q1 2021 was Suvretta Capital Management, an estimated $18.9M added.
  • The largest Fulcrum Therapeutics seller in Q1 2021 was Point72 Asset Management, an estimated $9.43M sold.

Based on aggregated 13F filings for Q1 2021.